At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 98 enrolled
Drug / intervention
Ketaminedrug
Likely dose
Ketamine 0.15 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Controlled Trial of Intravenous Sub-dissociative Ketamine at Two Doses for Analgesia in the Emergency Department
In Brief
A Phase 4 clinical trial evaluating Ketamine for Acute Pain. Completed, enrolled 98 participants across 1 site.
Detailed Summary
Goal is to determine if in adults presenting to the Emergency Department (ED) with moderate to severe acute pain, Ketamine administered at 0.15 mg/kg will provide similar pain relief to Ketamine administered at 0.3 mg/kg, with fewer adverse effects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Pain
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20192020202120222023202420252026
Enrollment StartOct 2018
First PostedOct 2018
Primary CompletionSep 2019
TodayJul 2026
First PostedOct 22, 2018
Enrollment StartOct 15, 2018
Primary CompletionSep 17, 2019
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 7.7 years ago
Interventions
Ketaminedrug
Ketamine 0.15 mg/kg vs. 0.3 mg/kg IVPB over 15 minutes